Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Assessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp.

dc.contributor.authorSierra Urueña, Yanik
dc.contributor.authorTubau, Fe
dc.contributor.authorGonzález Díaz, Aida
dc.contributor.authorCarrera Salinas, Anna
dc.contributor.authorMoleres, Javier
dc.contributor.authorBajanca-Lavado, Paula
dc.contributor.authorGarmendia, J.
dc.contributor.authorDomínguez Luzón, Ma. Ángeles (María Ángeles)
dc.contributor.authorArdanuy Tisaire, María Carmen
dc.contributor.authorMartí Martí, Sara
dc.date.accessioned2022-02-24T15:49:11Z
dc.date.available2022-02-24T15:49:11Z
dc.date.issued2020-07-01
dc.date.updated2022-02-24T15:49:11Z
dc.description.abstractObjectives: To compare the determinants of trimethoprim-sulfamethoxazole resistance with established susceptibility values for fastidious Haemophilus spp., to provide recommendations for optimal trimethoprim-sulfamethoxazole measurement. Methods: We collected 50 strains each of Haemophilus influenzae and Haemophilus parainfluenzae at Bellvitge University Hospital. Trimethoprim-sulfamethoxazole susceptibility was tested by microdilution, E-test and disc diffusion using both Mueller-Hinton fastidious (MH-F) medium and Haemophilus test medium (HTM) following EUCAST and CLSI criteria, respectively. Mutations in folA, folP and additional determinants of resistance were identified in whole-genome-sequenced isolates. Results: Strains presented generally higher rates of trimethoprim-sulfamethoxazole resistance when grown on HTM than on MH-F, independent of the methodology used (average MIC 2.6-fold higher in H. influenzae and 1.2-fold higher in H. parainfluenzae). The main resistance-related determinants were as follows: I95L and F154S/V in folA; 3- and 15-bp insertions and substitutions in folP; acquisition of sul genes; and FolA overproduction potentially linked to mutations in -35 and -10 promoter motifs. Of note, 2 of 19 H. influenzae strains (10.5%) and 9 of 33 H. parainfluenzae strains (27.3%) with mutations and assigned as resistant by microdilution were inaccurately considered susceptible by disc diffusion. This misinterpretation was resolved by raising the clinical resistance breakpoint of the EUCAST guidelines to ≤30 mm. Conclusions: Given the routine use of disc diffusion, a significant number of strains could potentially be miscategorized as susceptible to trimethoprim-sulfamethoxazole despite having resistance-related mutations. A simple modification to the current clinical resistance breakpoint given by the EUCAST guideline for MH-F ensures correct interpretation and correlation with the reference standard method of microdilution.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec709403
dc.identifier.issn1198-743X
dc.identifier.pmid31811916
dc.identifier.urihttps://hdl.handle.net/2445/183494
dc.language.isoeng
dc.publisherEuropean Society of Clinical Microbiology and Infectious Diseases
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.cmi.2019.11.022
dc.relation.ispartofClinical Microbiology and Infection, 2020, vol. 26, num. 7
dc.relation.urihttps://doi.org/10.1016/j.cmi.2019.11.022
dc.rights(c) Sierra Urueña, Yanik et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationMalalties bacterianes
dc.subject.classificationAntibiòtics
dc.subject.classificationEstabilitat dels medicaments
dc.subject.classificationBacils
dc.subject.otherBacterial diseases
dc.subject.otherAntibiotics
dc.subject.otherDrug stability
dc.subject.otherBacillus (Bacteria)
dc.titleAssessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
709403.pdf
Mida:
1.19 MB
Format:
Adobe Portable Document Format